What your participation means to global health
Through the generous support of our 19,114 ASPREE participants we were able to provide scientific evidence on the benefits versus the risks of aspirin for ‘primary prevention’ (to prevent a first heart attack or stroke) in healthy older people. Three ASPREE research papers were published in one issue of the New England Journal of Medicine in September 2018.
- Effect of Aspirin on Disability-free Survival in the Healthy Elderly (primary paper)
- Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
- Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly
More ASPREE trial results are expected to be published in 2019.